Novavax Inc (NVAX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$8.16

Buy

$8.22

arrow-up$0.05 (+0.62%)

Prices updated at 01 Apr 2026, 00:59 EDT

Prices minimum 15 mins delay

Prices in USD

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

NASDAQ

3.83%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$8.39 - $7.72
	$11.97 - $5.01
	-
	1,642.86m
	3.14
	-
	5,998,569
	-
	6,228,634.03
	2.84
	164.97m
	US6700024010
	2.58
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.